OCT and OCTA are complementary. OCT is optimized for depth-resolved structure; OCTA compares repeated scans to infer motion from flowing blood and build vascular maps. OCTA adds flow information, but it does not show dye leakage and is particularly sensitive to artifacts.
- OCT asks primarily: what does the tissue look like in cross-section?
- OCTA asks primarily: where is motion consistent with blood flow detected within segmented retinal and choroidal slabs?
- Neither modality makes the other obsolete; each has blind spots that can be clinically important.
Same family, different question
OCTA is built on OCT acquisition, but it changes what repeated measurements are used to reveal. Structural OCT reconstructs reflectivity through depth and shows anatomy such as retinal layers, fluid and tissue contours. OCT angiography repeatedly scans the same location and looks for changes in signal associated with moving red blood cells. The resulting data can be displayed as en-face vascular maps at different depths. This shared origin explains why the names sound similar—and why the outputs answer different questions.
What standard OCT is best at
Structural OCT is strongest when the problem is anatomical. It can show whether the retina is thickened or thinned, whether fluid is intraretinal or subretinal, whether the retinal pigment epithelium is elevated, and whether traction or a membrane is distorting the macula. It is also the basis for many automated measurements and longitudinal comparisons. What it does not directly provide is a map of perfused capillaries or a direct demonstration of dye leakage.
What OCTA adds
OCTA uses motion contrast. One influential approach, split-spectrum amplitude-decorrelation angiography, improved flow detection by comparing repeated B-scans and averaging decorrelation across spectral bands. Modern systems use related proprietary algorithms, but the central idea is similar: stationary tissue should remain relatively stable while moving blood changes the signal. Because the scan is depth-resolved, software can segment slabs corresponding to superficial, deep and choroidal vascular layers. That depth information is a major advantage over a single two-dimensional projection.
Why OCTA can look more detailed than dye angiography
Because OCTA does not depend on fluorescent dye spreading through the circulation, small vascular networks can appear sharply delineated without being obscured by leakage. In studies of neovascularization, OCTA has been able to display vessel morphology and, in some settings, detect networks that are difficult to characterize on conventional angiography alone. But a clean vascular map can create false confidence. Flow below the detection threshold may disappear, segmentation can put vessels in the wrong slab, and shadowing can erase real structures.
Why fluorescein angiography still answers something OCTA cannot
Fluorescein angiography records the passage of injected dye through the retinal circulation. That makes leakage visible—a dynamic property OCTA does not directly measure. OCTA shows a motion-derived vascular network; FA shows filling patterns and leakage over time. In neovascular disease, those are not interchangeable pieces of information. Comparative studies have shown useful agreement in some lesions but also differences in detectability and lesion characterization.
Artifacts change the comparison
OCTA is especially vulnerable to motion, low signal, segmentation and projection artifacts. Retinal pathology itself can make segmentation less reliable. In one study across multiple chorioretinal diseases, segmentation errors were common in diseased eyes and particularly frequent in neovascular AMD. The implication is practical: a vascular map should be checked against the underlying structural B-scan and image-quality context before being treated as a literal map of perfusion.
When one scan is not enough
A structural OCT may be the decisive test for fluid or traction. OCTA may be valuable when vascular architecture or nonperfusion is the question. FA may still be needed when leakage or dynamic filling matters. Multimodal imaging exists because retinal disease is multidimensional. The best modality is therefore task-dependent rather than universally superior.
The simplest way to remember the difference
Think structure versus flow—with an asterisk. OCT primarily maps structure. OCTA derives flow-related contrast from repeated OCT measurements. The asterisk is that both are computational reconstructions with device-specific processing, and neither is self-interpreting. The more convincing the image looks, the more important it is to remember how it was produced.
How the two appear together in modern software
Many commercial platforms display structural B-scans, en-face OCT and OCTA slabs side by side. That co-registration is more than a convenience. A suspicious vascular signal on OCTA can be checked against the exact cross-sectional location, while a structural abnormality can be examined for corresponding flow. The strongest interpretation often comes from this linked view rather than from any isolated panel.
Quantification is tempting—and fragile
OCTA software can report vessel density, perfusion density, foveal avascular zone area and other metrics. Structural OCT can report retinal or layer thickness. These numbers invite comparison, but each inherits the acquisition and segmentation choices of the device. Cross-platform thresholds should therefore be treated cautiously. A useful quantitative biomarker needs repeatability within a system and validation across the population and disease in which it will be used.
Performance and appearance vary across OCT/OCTA devices and processing algorithms. This comparison describes principles, not a rule for choosing imaging in an individual patient.
Sources & original records
We prioritize primary records, clinical-trial registries, peer-reviewed literature and authoritative institutions. Manufacturer material is labeled when used to describe a product or company position.
- Split-spectrum amplitude-decorrelation angiography with optical coherence tomographyPubMed · Primary methods study · PMID 22418228
- A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 NeovascularizationPubMed · 2016 · Multicenter comparative study · PMID 27409488 · DOI 10.1167/iovs.15-18900
- Prevalences of segmentation errors and motion artifacts in OCT-angiography differ among retinal diseasesPubMed · 2018 · Artifact study · PMID 29982897 · DOI 10.1007/s00417-018-4053-2